An Evaluation of Low Level Laser Light Therapy on Improving the Symptoms of Alzheimer's Disease

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

June 15, 2020

Study Completion Date

October 15, 2020

Conditions
Alzheimer's Disease
Interventions
DEVICE

Erchonia ALS Laser

The Erchonia ALS Laser is administered to the subject's frontal cortex, temporal regions and base of the skull 8 times across 4 consecutive weeks, 2 times each week, for 10 minutes of treatment time per administration. The total energy delivered to the subject per procedure administration is 22.5 joules.

DEVICE

Placebo Laser

The Placebo Laser is administered to the subject's frontal cortex, temporal regions and base of the skull 8 times across 4 consecutive weeks, 2 times each week, for 10 minutes of treatment time per administration. There is no energy delivered to the subject.

Trial Locations (2)

20926

Neocemod, La Plazuela

45110

Pruebas Clinicas, Zapopan

Sponsors
All Listed Sponsors
lead

Erchonia Corporation

INDUSTRY